A-834,735
http://dbpedia.org/resource/A-834,735 an entity of type: Thing
A-834,735 is a drug developed by Abbott Laboratories that acts as a potent cannabinoid receptor full agonist at both the CB1 and CB2 receptors, with a Ki of 12 nM at CB1 and 0.21 nM at CB2. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in most indole derived cannabinoids, with the 3-tetramethylcyclopropylmethanone group of A-834,735 and related compounds, imparts significant selectivity for CB2, with most compounds from this group found to be highly selective CB2 agonists with little affinity for CB1. However low nanomolar CB1 binding affinity is retained with certain heterocyclic 1-position substituents such as (N-methylpiperidin-2-yl)methyl (cf. AM-1220, AM-1248), or the (tetrahydropyran-4-yl)methyl substituent of A-834,735, resulting in compounds that still show significan
rdf:langString
rdf:langString
A-834,735
xsd:integer
30404865
xsd:integer
1082421017
xsd:integer
22
xsd:integer
895155
xsd:integer
271158
xsd:integer
9719418
xsd:integer
29
rdf:langString
{1-[methyl]-1H-indol-3-yl}-methanone
rdf:langString
Class B
xsd:integer
1
xsd:integer
2
xsd:integer
11544639
rdf:langString
C4COCCC4Cnc2ccccc2c3CC1CC1C
xsd:integer
1
rdf:langString
NQTMRZNYLIGQCF-UHFFFAOYSA-N
rdf:langString
XE27L67C93
rdf:langString
changed
xsd:integer
456505675
rdf:langString
changed
rdf:langString
A-834,735 is a drug developed by Abbott Laboratories that acts as a potent cannabinoid receptor full agonist at both the CB1 and CB2 receptors, with a Ki of 12 nM at CB1 and 0.21 nM at CB2. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in most indole derived cannabinoids, with the 3-tetramethylcyclopropylmethanone group of A-834,735 and related compounds, imparts significant selectivity for CB2, with most compounds from this group found to be highly selective CB2 agonists with little affinity for CB1. However low nanomolar CB1 binding affinity is retained with certain heterocyclic 1-position substituents such as (N-methylpiperidin-2-yl)methyl (cf. AM-1220, AM-1248), or the (tetrahydropyran-4-yl)methyl substituent of A-834,735, resulting in compounds that still show significant affinity and efficacy at both receptors despite being CB2 selective overall.
xsd:nonNegativeInteger
5802
xsd:string
895155-57-4
xsd:string
271158
xsd:string
XE27L67C93
xsd:string
11544639